> Take me to the Patient area

Patient Info

What is Constipation?

Below you will find a brief overview of constipation which covers the definition, incidence in the UK, types of constipation and lifestyle factors that can cause constipation. For a more in-depth review of constipation, please visit the NICE Clinical knowledge summary on constipation: http://cks.nice.org.uk/constipation

A normal bowel movement frequency is currently defined as occurring between three-times a day to once every three days. A patient is regarded as suffering from constipation if they have defecation that is unsatisfactory owing to infrequent stools, difficulty in passing stools or seemingly incomplete defaecation. Stools often appear dry, hard, and abnormally large or small.1,2

A UK primary care cohort study found the prevalence of GP-diagnosed constipation ranged from 12 per 1000 people in 2005 to 12.8 per 1000 people in 20092

Constipation is more common with increasing age.2

The incidence of constipation is 2–3 times higher in women than in men.2

Constipation is more common during pregnancy than in the general population, affecting about 40% of women.2

Types of Constipation
There are two main types of constipation, functional constipation and organic constipation.

Functional (primary or idiopathic) constipation
Functional constipation is chronic constipation without a known cause.2

Secondary (organic) constipation
Organic constipation is caused by medication or an underlying medical condition.2

Risk Factors
There are many social and psychological factors that can increase the risk of constipation in adults, including a low fibre diet, lack of exercise/reduced mobility, anxiety and depression.2

Constipation Resources
Please click the links below to leave the Aspire Pharma website and find out more information about constipation.

Aspire Pharma is not responsible for the content on external websites.







References: 1) www.patient.co.uk/doctor/constipation-in-adults (accessed July 2020) 2) NICE Clinical Knowledge summary on Constipation (http://cks.nice.org.uk/constipation) (accessed July 2020)

For further information, please call: 01730 231148, email: info@aspirepharma.co.uk
or visit www.aspirepharma.co.uk

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148
For more information about Lecicarbon, please see the abbreviated prescribing information.
Revision reference – Lecicarbon_9_27/07/2020